References
- Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Kardiol Pol. 2018;76:1585-1664; DOI: 10.5603/KP.2018.0228.30566213
- Cuminetti G, Gelsomino S, Curello S, Lorusso R, Maessen JG, Hoorntje JC. Contemporary use of arterial and venous conduits in coronary artery bypass grafting: anatomical, functional and clinical aspects. Neth Heart J. 2017; 25: 4-13; DOI: 10.1007/s12471-016-0919-2.2787854810.1007/s12471-016-0919-2
- Perek B, Misterski M, Stachowiak W, Buczkowski P, Stefaniak S, Puślecki M et al. The impact of coronary artery disease severity on late survival after combined aortic valve replacement and coronary artery bypass grafting - experience of a single cardiac surgery center. Kardiochir Torakochirurgia Pol. 2014;11:361-366. DOI: 10.5114/kitp.2014.47333.26336450
- Tugtekin SM, Alexiou K, Kappert U, Esche H, Joskowiak D, Knaut M et al. Coronary reoperation with and without cardiopulmonary bypass. Clin Res Cardiol. 2006;95:93-98; DOI: 10.1007/s00392-006-0335-5.1659851710.1007/s00392-006-0335-5
- Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Longterm (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary artery bypass grafts. J Thorac Cardiovasc Surg. 1985;89:248-258.10.1016/S0022-5223(19)38820-8
- Zhang H, Wang ZW, Wu HB, Hu XP, Zhou Z, Xu P. Radial artery graft vs. saphenous vein graft for coronary artery bypass surgery: which conduit offers better efficacy? Herz 2014;39: 458-465; DOI: 10.1007/s00059-013-3848-5.10.1007/s00059-013-3848-523784362
- Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U et al. Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. N Engl J Med. 2016;375:2540-2549. DOI: 10.1056/NEJMoa1610021.2795971210.1056/NEJMoa1610021
- Kieser TM, Curran HJ, Rose MS, Norris CM, Graham MM. Arterial grafts balance survival between incomplete and complete revascularization: a series of 1000 consecutive coronary artery bypass graft patients with 98% arterial grafts. J Thorac Cardiovasc Surg. 2014;147:75-83; DOI: 10.1016/j.jtcvs.2013.08.003.10.1016/j.jtcvs.2013.08.00324084283
- Perek B, Malińska A, Nowicki M, Misterski M, Ostalska-Nowicka D, Jemielity M. Histological evaluation of age-related variations in saphenous vein grafts used for coronary artery bypass grafting. Arch Med Sci. 2012;8:1041-1047; DOI: 10.5114/aoms.2012.32412.23319979
- Perek B, Malinska A, Stefaniak S, Ostalska-Nowicka D, Misterski M, Zabel M et al. Predictive factors of late venous aortocoronary graft failure: ultrastructural studies. PLoS One. 2013;8:e70628; DOI: 10.1371/journal.pone.0070628.10.1371/journal.pone.007062823940610
- Perek B, Malinska A, Misterski M, Ostalska-Nowicka D, Zabel M, Perek A et al. Preexisting high expression of matrix metalloproteinase-2 in tunica media of saphenous vein conduits is associated with unfavorable longterm outcomes after coronary artery bypass grafting. Biomed Res Int. 2013;2013:730721; DOI: 10.1155/2013/730721.
- Perek B, Malińska A, Ostalska-Nowicka D, Puślecki M, Ligowski M, Misterski M et al. Cytokeratin 8 in venous grafts: a factor of unfavorable long-term prognosis in coronary artery bypass grafting patients. Cardiol J. 2013;20:583-591; DOI: 10.5603/CJ.2013.0142.2433853410.5603/CJ.2013.0142
- Perek B, Kowalska K, Nowicki M, Kempisty B, Puślecki M, Jankowski M et al. Variability in gelatinase expression in the walls of vessels used as aortocoronary conduits may impact long-term graft patency. Kardiol Pol. 2019;77:217-224; DOI: 10.5603/KP.a2019.0015.
- Hassantash SA, Bikdeli B, Kalantarian S, Sadeghian M, Afshar H. Pathophysiology of aortocoronary saphenous vein bypass graft disease. Asian Cardiovasc Thorac Ann. 2008;16:331-336.10.1177/02184923080160041818670032
- Hilker M, Tellmann G, Buerke M, Gloger K, Moersig W, Oelert H et al. Proliferative activity in stenotic human aortocoronary bypass grafts. Cardiovasc Pathol. 2002;11:284-290; DOI: 10.1016/s1054-8807(02)00113-8.10.1016/S1054-8807(02)00113-812361839
- Schlitt A, Pruefer D, Buerke U, Russ M, Dahm M, Oelert H et al. Neutrophil adherence to activated saphenous vein and mammary endothelium after graft preparation. Ann Thorac Surg. 2006;81:1262-1268; DOI: 10.1016/j.athoracsur.2005.09.073.1656425510.1016/j.athoracsur.2005.09.073
- Perek B, Kowalska K, Kempisty B, Nowicki A, Jankowski M, Nawrocki MJ et al. Role of macrophages in the pathogenesis of atherosclerosis and aortocoronary graft disease. J Biol Regul Homeost Agents. 2018;32:1055-1059.30334398
- Malinska A, Perek B, Buczkowski P, Kowalska K, Ostalska-Nowicka D, Witkiewicz W et al. CD68 expression in aortocoronary saphenous vein bypass grafts. Histochem Cell Biol. 2013;140:183-188; DOI: 10.1007/ s00418-012-1069-2.10.1007/s00418-012-1069-223275124
- Perek B, Kowalska K, Kempisty B, Nawrocki M, Nowicki M, Puślecki M et al. Infiltration of CD68+ cells correlates positively with matrix metalloproteinase 2 expression in the arteries used as aortocoronary bypass grafts. Possible clinical implications. Cardiol J. 2019 Sep 6; DOI: 10.5603/CJ.a2019.0087. [Epub ahead of print]
- Perek B, Kowalska K, Kempisty B, Nowicki M, Dyszkiewicz-Konwińska M, Puślecki M, et al. Gender and age-related variability of macrophage representation in the internal thoracic artery wall: does it matter? J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):791-802.
- Chung JH, Jeon HJ, Hong SY, Lee DL, Lee KH, Kim SH et al. Palmitate promotes the paracrine effects of macrophages on vascular smooth muscle cells: the role of bone morphogenetic proteins. PLoS One. 2012; 7: e29100; DOI: 10.1371/journal.pone.0029100.10.1371/journal.pone.002910022363399
- Chatrou ML, Cleutjens JP, van der Vusse GJ, Roijers RB, Mutsaers PH, Schurgers LJ. Intra-Section analysis of human coronary arteries reveals a potential role for micro-calcifications in macrophage recruitment in the early stage of atherosclerosis. PLoS One. 2015;10:e0142335; DOI: 10.1371/journal.pone.0142335.10.1371/journal.pone.014233526555788
- Zhu Y, Chen A, Wang Z, Liu J, Cai J, Zhou M, Zhao Q. Ten-year real-life effectiveness of coronary artery bypass using radial artery or great saphenous vein grafts in a single centre Chinese hospital. Interact Cardiovasc Thorac Surg. 2017;25:559-564; DOI: 10.1093/icvts/ivx174.10.1093/icvts/ivx174
- Petrovic I, Nezic D, Peric M, Milojevic P, Djokic O, Kosevic D et al. Radial artery vs saphenous vein graft used as the second conduit for surgical myocardial revascularization: long-term clinical follow-up. J Cardiothorac Surg. 2015;10:127; DOI: 10.1186/s13019-015-0331-9.10.1186/s13019-015-0331-926466996
- Qi D, Wei M, Jiao S, Song Y, Wang X, Xie G et al. Hypoxia inducible factor 1α in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment. Cell Death Dis. 2019;10:544; DOI: 10.1038/s41419-019-1757-0.10.1038/s41419-019-1757-031320613
- Harwani SC. Macrophages under pressure: the role of macrophage polarization in hypertension. Transl Res. 2018;191:45-63; DOI: 10.1016/j.trsl.2017.10.011.2917203510.1016/j.trsl.2017.10.011
- Ahmed M, de Winther MPJ, Van den Bossche J. Epigenetic mechanisms of macrophage activation in type 2 diabetes. Immunobiology. 2017;222:937-943; DOI: 10.1016/j.imbio.2016.08.011.10.1016/j.imbio.2016.08.01127613200
- Malinska A, Podemska Z, Perek B, Jemielity M, Buczkowski P, Grzymislawska M et al. Preoperative factors predicting saphenous vein graft occlusion in coronary artery bypass grafting: a multivariate analysis. Histochem Cell Biol. 2017;148:417-424; DOI: 10.1007/s00418-017-1574-4.10.1007/s00418-017-1574-428478589
- Nowicki M, Misterski M, Malinska A, Perek B, Ostalska-Nowicka D, Jemielity M et al. Endothelial integrity of radial artery grafts harvested by minimally invasive surgery--immunohistochemical studies of CD31 and endothelial nitric oxide synthase expressions: a randomized controlled trial. Eur J Cardiothorac Surg. 2011;39:471-477; DOI: 10.1016/j.ejcts.2010.08.005.10.1016/j.ejcts.2010.08.00520851617